Nanalysis Scientific (NSCI) Q4 2024 (Q&A) earnings summary

Executive summary

• Achieved record quarterly revenue of $12.3M (up 25% YoY) and annual revenue of $45.5M (up 60% YoY) for 2024, with all business segments showing simultaneous progress for the first time.

• Adjusted EBITDA reached $1.8M in Q4 and $2.8M for the year, both record highs, with positive gross margins and improved operational efficiency.

• Revenue growth was driven by expansion in both product sales and security services segments.

• Focus remains on significant revenue growth and expanding profit margins over the next five years.

Financial highlights

• Q4 2024 revenue: $12.3M (+25% YoY); full year: $45.5M (+60% YoY).

• Q4 gross margin: 60% for product sales (vs. 48% prior year); 16% for service revenue (vs. -27%).

• Adjusted EBITDA: $1.8M in Q4 (vs. -$0.7M prior year); $2.8M for 2024 (vs. -$7.9M prior year).

• Normalized net loss for Q4: $0.4M (vs. $2.1M prior year); for 2024: $6.3M (vs. $14.0M prior year).

• Positive operating cash flow: $1.1M in Q4 and $3.3M for the year (vs. negative $2.6M and $11.2M prior year).

Outlook and guidance

• Expects continued revenue growth in Security Services and improved gross margins in 2025, with ongoing cost efficiency improvements that will not impact revenue growth or innovation.

• Positive Adjusted EBITDA expected to continue through 2025.

• Some downward pressure on product sales anticipated in H1 2025 due to global tariff uncertainty, but mitigation measures in place.

• Plans to maintain strong investment in R&D and product development, ensuring ongoing innovation.